24 Results for "

Chronic anemia

" in MedChemExpress (MCE) Product Catalog:
Products (24)

24 Results for "Chronic anemia" in MCE Product Catalog:

20
20 Publications Verification
Cat. No.: HY-17608
CAS No.: 960539-70-2
Synonyms: GSK1278863
Research Areas:  

Cardiovascular Disease

Daprodustat (GSK1278863) is an orally active hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor being developed for the treatment of anemia associated with chronic kidney disease.
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-101277
CAS No.: 1000025-07-9
Purity:  99.83%
Synonyms: PG-1016548; AKB-6548
Research Areas:  

Cardiovascular Disease

Vadadustat (PG-1016548) is a titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor . Vadadustat is an erythropoiesis-stimulating agent and has the potential for anemia treatment in chronic kidney disease in vivo .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-12654
CAS No.: 1154028-82-6
Purity:  98.58%
Synonyms: BAY 85-3934
Research Areas:  

Cardiovascular Disease

Molidustat (BAY 85-3934) is an orally active inhibitor of hypoxia-inducible factor prolyl hydroxylase (HIF-PH) with IC50 values of 480 nM, 280 nM, and 450 nM for PHD1, PHD2, and PHD3, respectively. Molidustat can elevate the levels of circulating erythropoietin (EPO) to near-normal physiological ranges. Molidustat can be utilized in the research of renal anemia .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-N1428C
CAS No.: 3522-50-7
Synonyms: Iron(III) citrate; Zerenex
Ferric citrate (Iron(III) citrate), an orally active iron supplement, is an efficacious phosphate binder. Ferric citratee can be used for iron deficiency anemia and chronic kidney disease (CKD) research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-Y1103
CAS No.: 7782-63-0
Synonyms: Ferrous sulfate heptahydrate, 99%
Iron(II) sulfate heptahydrate, 99% (Ferrous sulfate heptahydrate, 99%) is an orally active iron salt. Iron(II) sulfate heptahydrate, 99% replaces iron found in hemoglobin and myoglobin, allowing for the transportation of oxygen via hemoglobin. Iron(II) sulfate heptahydrate, 99% is mainly used for the prevention of iron-deficiency anemia. Iron(II) sulfate heptahydrate, 99% also has anti-tumor effects on chronic myeloid leukemia and breast cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-Y1103A
CAS No.: 7782-63-0
Synonyms: Ferrous sulfate heptahydrate, for cell culture, 99%
Iron(II) sulfate heptahydrate, for cell culture, 99% (Ferrous sulfate heptahydrate, for cell culture, 99%) is an orally active iron salt. Iron(II) sulfate heptahydrate, for cell culture, 99% replaces iron found in hemoglobin and myoglobin, allowing for the transportation of oxygen via hemoglobin. Iron(II) sulfate heptahydrate, for cell culture, 99% is mainly used for the prevention of iron-deficiency anemia. Iron(II) sulfate heptahydrate, for cell culture, 99% also has anti-tumor effects on chronic myeloid leukemia and breast cancer .
loading...
    loading...
Cat. No.: HY-47030
CAS No.: 2338-05-8
Ferric citrate hydrate, an orally active iron supplement, is an efficacious phosphate binder. Ferric citrate hydrate can be used for iron deficiency anemia and chronic kidney disease (CKD) research .
loading...
    loading...
Cat. No.: HY-P3761
CAS No.: 147821-01-0
Target:  

Caspase

Research Areas:  

Inflammation/Immunology

Ac-Tyr-Val-Lys-Asp-aldehyde is a reversible caspase-1 inhibitor. Ac-Tyr-Val-Lys-Asp-aldehyde increases GATA1 levels by inhibiting caspase-1 and promotes erythroid differentiation. can be used for disease research including anemia-associated to chronic diseases, chemotherapy-induced anemia and Diamond-Blackfan anemia .
loading...
    loading...
Cat. No.: HY-17608R
CAS No.: 960539-70-2
Synonyms: GSK1278863 (Standard)
Daprodustat (Standard) is the analytical standard of Daprodustat. This product is intended for research and analytical applications. Daprodustat (GSK1278863) is an orally active hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor being developed for the treatment of anemia associated with chronic kidney disease.
loading...
    loading...
Cat. No.: HY-101277S1
Synonyms: PG-1016548-13C6; AKB-6548-13C6
Vadadustat- 13C6 (PG-1016548- 13C6) is 13C labeled Vadadustat. Vadadustat (PG-1016548) is a titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor . Vadadustat is an erythropoiesis-stimulating agent and has the potential for anemia treatment in chronic kidney disease in vivo .
loading...
    loading...
Cat. No.: HY-125288
CAS No.: 2247168-13-2
Target:  

Ferroportin

Research Areas:  

Metabolic Disease

DS42450411 is an orally active hepcidin production inhibitor with an IC50 of 32 nM. DS42450411 in an acute inflammatory mouse model induced by IL-6, DS42450411 significantly reduces serum hepcidin levels. DS42450411 can be used for studying iron homeostasis .
loading...
    loading...
Cat. No.: HY-W747868
CAS No.: 1375799-59-9
Research Areas:  

Cardiovascular Disease

Molidustat sodium is an orally active inhibitor of hypoxia-inducible factor prolyl hydroxylase (HIF-PH) with IC50 values of 480 nM, 280 nM, and 450 nM for PHD1, PHD2, and PHD3, respectively. Molidustat sodium can elevate the levels of circulating erythropoietin (EPO) to near-normal physiological ranges. Molidustat sodium can be utilized in the research of renal anemia .
loading...
    loading...
Cat. No.: HY-P990965
CAS No.: 2761347-19-5

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology

Efparepoetin alfa is an EPO receptor agonist. Efparepoetin alfa can be used in the research of anemia caused by chronic kidney disease .
loading...
    loading...
Cat. No.: HY-170915
CAS No.: 1842340-93-5
Research Areas:  

Others

DDO-3055 is an orally active PHD2 inhibitor that can be used in the research of anemia associated with chronic kidney disease .
loading...
    loading...
Cat. No.: HY-P5908
Target:  

Peptides

Research Areas:  

Cardiovascular Disease

DEALA-Hyp-YIPD is an HIF-1α peptide that inhibits VHL/HIF-1α interaction with an IC50 of 0.91 μM and a Kd of 180 nM .
loading...
    loading...
Cat. No.: HY-163148
CAS No.: 2924181-77-9
Research Areas:  

Cardiovascular Disease

PHD-IN-3 (Compound 15) is an orally active PHD inhibitor. PHD-IN-3 can be used in the study of anemia associated with chronic kidney disease .
loading...
    loading...
Cat. No.: HY-124133
CAS No.: 1238689-36-5
Research Areas:  

Cardiovascular Disease

JNJ-42905343 is an orally active and highly selective prolyl hydroxylase (PHD1/2/3) inhibitor with pKI values of 8.07, 7.48 and 7.27 for PHD1, PHD2 and PHD3, respectively. JNJ-42905343 is promising for research of functional iron deficiency (FID) and anemia of chronic disease (ACD) .
loading...
    loading...
Cat. No.: HY-170917
CAS No.: 2924181-60-0
PHD2-IN-4 (compound 1) is a PHD2 inhibitor. PHD2-IN-4 inhibits PHD2 with an IC50 of 4 nM. PHD2-IN-4 is potential for chronic kidney disease research .
loading...
    loading...
Cat. No.: HY-170914
CAS No.: 1258877-17-6
Research Areas:  

Metabolic Disease

JPHM-2-167 (Compound 11) is a selective PHD (prolyl hydroxylase domain enzyme) inhibitor. JPHM-2-167 inhibits PHD2, PHD3 with IC50s of 0.253 μM and 3.95 μM, respectively. JPHM-2-167 can be used for chronic kidney disease .
loading...
    loading...
Cat. No.: HY-12654R
CAS No.: 1154028-82-6
Synonyms: BAY 85-3934 (Standard)
Molidustat (Standard) is the analytical standard of Molidustat. This product is intended for research and analytical applications. Molidustat (BAY 85-3934) is an orally active inhibitor of hypoxia-inducible factor prolyl hydroxylase (HIF-PH) with IC50 values of 480 nM, 280 nM, and 450 nM for PHD1, PHD2, and PHD3, respectively. Molidustat can elevate the levels of circulating erythropoietin (EPO) to near-normal physiological ranges. Molidustat can be utilized in the research of renal anemia .
loading...
    loading...